Credit Suisse’s VolitionRx Ltd VNRX Stock Holding History

Credit Suisse’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,477	Closed	-$92K	–	4679
2021 Q3	$92K	Sell	1,477 -113	-7%	-$7.16K	﹤0.01%	4324
2021 Q2	$104K	Buy	+1,590	New	+$108K	﹤0.01%	4364
2019 Q3	–	Sell	-1,850	Closed	-$116K	–	4265
2019 Q2	$116K	Sell	1,850 -1,400	-43%	-$90.7K	﹤0.01%	3937
2019 Q1	$211K	Hold	3,250	–	–	﹤0.01%	3743
2018 Q4	$118K	Hold	3,250	–	–	﹤0.01%	3750
2018 Q3	$168K	Hold	3,250	–	–	﹤0.01%	3680
2018 Q2	$130K	Hold	3,250	–	–	﹤0.01%	3808
2018 Q1	$156K	Buy	+3,250	New	+$190K	﹤0.01%	3737
2015 Q3	–	Sell	-598	Closed	-$47K	–	4489
2015 Q2	$47K	Hold	598	–	–	﹤0.01%	4467
2015 Q1	$49K	Buy	+598	New	+$49.5K	﹤0.01%	4282

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse's VNRX Position: Q4 2021 in Review

Credit Suisse sold out of VolitionRx Ltd (VNRX) in Q4 2021, closing a stake of 1,477 shares — an estimated $92K sold.

Credit Suisse first reported a position in VNRX in Q1 2015 and held it in 10 quarters. The position peaked at $211K in Q1 2019. 36 funds tracked by Wall St. Rank hold VNRX as of Q4 2021.

Credit Suisse reported no remaining VolitionRx Ltd position as of Q4 2021 after selling out during the quarter.
Credit Suisse sold 1,477 VolitionRx Ltd shares in Q4 2021, an estimated $92K.
Credit Suisse first reported a position in VolitionRx Ltd in Q1 2015 and held it in 10 quarters.
Credit Suisse's VolitionRx Ltd position peaked at $211K in Q1 2019.
36 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2021.

Based on Credit Suisse's 13F filing for Q4 2021, filed 14 Feb 2022.